When we discuss infrastructure in America, we typically envision the roads, bridges and power lines that enable us to travel and keep our homes functioning. But there is another vital system that ...

The Senate Banking Committee is shifting focus to housing legislation, following President Donald Trump’s executive order directing his administration to prevent large institutional investors from ...

The Senate Banking Committee postponed its scheduled markup of a key crypt bill this week after Coinbase CEO Brian Armstrong pulled support for its draft text. Shares of crypto companies such as ...

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using Biohaven's proprietary MoDE™ and next-generation, highly selective TRAP™ ...

The center-left think tank Third Way is urging Democrats to make data privacy a priority amid a separate effort by Republicans to develop legislation focused on the issue. In a memo released Wednesday ...

A comprehensive Clinic Queue Management System implemented in Java, demonstrating the effective use of Priority Queue data structure for managing patient queues in a healthcare environment. This ...

Billionaire investor Bill Ackman on Saturday proposed merging SpaceX with Pershing Square SPARC Holdings, a special purpose acquisition rights vehicle created by his firm, Pershing Square Capital ...

Electrical substation infrastructure increasingly sits at the front of data center project planning as utilities tighten grid access and require major power upgrades ...

The queue for power-intensive customers looking to tap into New York’s energy grid has surged as the boom for artificial intelligence and growth in large-scale manufacturing drive electricity demand, ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...